Clearside Biomedical, Inc.
USD0.41
+0.00 (+0.00%)
CEO
George Lasezkay
IPO Date
2016-06-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.41
Prev. Close
$0.41
Day Low
$0.41
Day High
$0.41
52W Low
$0.31
52W High
$17.10
Market Cap
$0.00B
Volume
2.05M
| 500,000 |
| $0.97 |
| 10 Jan 2025 | Deignan Charles A. | Chief Financial Officer | A-Award | Acquired | 200,000 | $0.97 |
| 21 Jun 2024 | Thorp Clay | director | A-Award | Acquired | 45,000 | $1.15 |
| 21 Jun 2024 | Humphries William D. | director | A-Award | Acquired | 45,000 | $1.15 |
| 21 Jun 2024 | Croarkin Richard | director | A-Award | Acquired | 45,000 | $1.15 |
| 21 Jun 2024 | EDWARDS JEFFREY L | director | A-Award | Acquired | 45,000 | $1.15 |
| 21 Jun 2024 | SHAFFER CHRISTY L | director | A-Award | Acquired | 45,000 | $1.15 |
| 21 Jun 2024 | Hutson Nancy J | director | A-Award | Acquired | 45,000 | $1.15 |
| 9 Feb 2024 | WHITMORE BRADFORD T | 10 percent owner | P-Purchase | Acquired | 444,444 | $1.35 |